000			01678 a2200505 4500
005			20250516105422.0
264		0	_c20130418
008			201304s 0 0 eng d
022			_a1573-2568
024	7		_a10.1007/s10620-012-2351-9 _2doi
040			_aNLM _beng _cNLM
100	1		_aJung, Yoon Suk
245	0	0	_aClinical course of intestinal Behcet's disease during the first five years. _h[electronic resource]
260			_bDigestive diseases and sciences _cFeb 2013
300			_a496-503 p. _bdigital
500			_aPublication Type: Journal Article
650	0	4	_aAdrenal Cortex Hormones _xtherapeutic use
650	0	4	_aAdult
650	0	4	_aAnti-Inflammatory Agents, Non-Steroidal _xtherapeutic use
650	0	4	_aBehcet Syndrome _xdrug therapy
650	0	4	_aDisease Progression
650	0	4	_aFemale
650	0	4	_aFollow-Up Studies
650	0	4	_aGastrointestinal Agents _xtherapeutic use
650	0	4	_aHumans
650	0	4	_aIntestinal Diseases _xmortality
650	0	4	_aMale
650	0	4	_aMesalamine _xtherapeutic use
650	0	4	_aMiddle Aged
650	0	4	_aMultivariate Analysis
650	0	4	_aPredictive Value of Tests
650	0	4	_aPrognosis
650	0	4	_aRecurrence
650	0	4	_aRemission Induction
650	0	4	_aRisk Factors
650	0	4	_aSeverity of Illness Index
650	0	4	_aSulfasalazine _xtherapeutic use
700	1		_aCheon, Jae Hee
700	1		_aPark, Soo Jung
700	1		_aHong, Sung Pil
700	1		_aKim, Tae Il
700	1		_aKim, Won Ho
773	0		_tDigestive diseases and sciences _gvol. 58 _gno. 2 _gp. 496-503
856	4	0	_uhttps://doi.org/10.1007/s10620-012-2351-9 _zAvailable from publisher's website
999			_c22030869 _d22030869